The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Shchukina T.V.

Almazov National Medical Research Center

Bisaga G.N.

Almazov National Medical Research Center

Malko V.A.

Almazov National Medical Research Center

Tolochko K.A.

Almazov National Medical Research Center

Topuzova M.P.

Almazov National Medical Research Center

Dadatsky A.Yu.

Almazov National Medical Research Center

Efimtsev A.Yu.

Almazov National Medical Research Center

Lepekhina A.S.

Almazov National Medical Research Center

Turchinskaya I.A.

Almazov National Medical Research Center

Alekseeva T.M.

Almazov National Medical Research Center

Study of neurodegeneration in multiple sclerosis using optical coherence tomography of the retina and magnetic resonance morphometry of the brain

Authors:

Shchukina T.V., Bisaga G.N., Malko V.A., Tolochko K.A., Topuzova M.P., Dadatsky A.Yu., Efimtsev A.Yu., Lepekhina A.S., Turchinskaya I.A., Alekseeva T.M.

More about the authors

Read: 1124 times


To cite this article:

Shchukina TV, Bisaga GN, Malko VA, et al. Study of neurodegeneration in multiple sclerosis using optical coherence tomography of the retina and magnetic resonance morphometry of the brain. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;125(7‑2):66‑72. (In Russ.)
https://doi.org/10.17116/jnevro202512507266

Recommended articles:
A comprehensive study of Alzheimer’s disease biomarkers in plasma and cere­brospinal fluid. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):43-53
Cognitive impairment in patients with multiple scle­rosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):67-73
Mole­cular mechanisms of acute disseminated ence­phalomyelitis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(7-2):7-11
The role of mono­cytes in the immu­nopathogenesis of multiple scle­rosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(7-2):23-27
Current epidemiology of MS with onset in childhood and adolescence (pediatric multiple scle­rosis). S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(7-2):34-38
Features of the clinical course of multiple scle­rosis as a factor in persistent disa­bility. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(7-2):39-44
Quantitative analysis of cere­brospinal fluid flow in multiple scle­rosis patients. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(7-2):45-50
A clinical case of X-linked adre­noleukodystrophy. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4):102-107
Arti­ficial inte­lligence capa­bilities in multiple scle­rosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5):14-21

References:

  1. Bisaga GN, Kovalenko AV, Isaeva GE, et al. The use of mesenchymal stem cells for optic nerve atrophy in patients with multiple sclerosis: a pilot study. Annaly klinicheskoj i eksperimental’noj nevrologii. 2017;10(2):26-31. (In Russ.). https://doi.org/10.18454/ACEN.2017.2.4
  2. Bastos A, Soares M, Guimarães J. Markers of secondary progression in multiple sclerosis. Mult Scler Rel Disord. 2024;91:105881. https://doi.org/10.1016/j.msard.2024.105881
  3. Pietroboni AM, Dell’Arti L, Caprioli M, et al. The loss of macular ganglion cells begins from the early stages of disease and correlates with brain atrophy in multiple sclerosis patients. Mult Scler. 2019;25(1):31-38.  https://doi.org/10.1177/1352458517740214
  4. Rocca MA, Valsasina P, Meani A, et al; MAGNIMS Study Group. Association of Gray Matter Atrophy Patterns With Clinical Phenotype and Progression in Multiple Sclerosis. Neurology. 2021;96(11):e1561-e1573. https://doi.org/10.1212/WNL.0000000000011494
  5. Parmar K, Fonov VS, Naegelin Y, et al. Regional Cerebellar Volume Loss Predicts Future Disability in Multiple Sclerosis Patients. Cerebellum. 2022;21(4):632-646.  https://doi.org/10.1007/s12311-021-01312-0.
  6. Malko VA, Sadovnichuk EA, Lepekhina AS, et al. Possibilities of magnetic resonance morphometry and laboratory biomarkers in studying the progression of multiple sclerosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;124(7-2):66-71. (In Russ.) https://doi.org/10.17116/jnevro202412407266
  7. Preziosa P, Filippi M; MAGNIMS Study Group. Association of Gray Matter Atrophy Patterns With Clinical Phenotype and Progression in Multiple Sclerosis. Neurology. 2021;96(11):e1561-e1573. https://doi.org/10.1212/WNL.0000000000011494
  8. Trufanov AG, Bisaga GN, Skulyabin DI, et al. The significance of degeneration of thalamic nuclei in relapsing-remitting and secondary progressive multiple sclerosis: results of neuropsychological and morphometric studies. Annaly klinicheskoj i eksperimental’noj nevrologii. 2020;14(3):21-30. (In Russ.). https://doi.org/10.25692/acen.2020.3.3
  9. Panneman EL, Coric D, Tran LMD, et al. Progression of Anterograde Trans-Synaptic Degeneration in the Human Retina Is Modulated by Axonal Convergence and Divergence. Neuroophthalmology. 2019;43(6):382-390.  https://doi.org/10.1080/01658107.2019.1599027
  10. Shchukina TV, Bisaga GN, Malko VA, et al. Optical coherence retinal tomography as a prognostic biomarker of multiple sclerosis progression. Rossijskij nevrologicheskij zhurnal. 2024;29(3):16-23. (In Russ.). https://doi.org/10.30629/2658-7947-2024-29-3-16-23
  11. Chiang FL, Wang Q, Yu FF, et al. Localised grey matter atrophy in multiple sclerosis is network-based: a coordinate-based meta-analysis. Clinical Radiology. 2019;74(10):816.e19-816.e28.  https://doi.org/10.1016/j.crad.2019.07.005
  12. Mey GM, DeSilva TM. Utility of the visual system to monitor neurodegeneration in multiple sclerosis. Front Mol Neurosci. 2023;16:1125115. https://doi.org/10.3389/fnmol.2023.1125115
  13. Rekik A, Aissi M, Rekik I, et al. Brain atrophy patterns in multiple sclerosis patients treated with natalizumab and its clinical correlates. Brain Behav. 2022;12(5):e2573. https://doi.org/10.1002/brb3.2573
  14. Huang SC, Pisa M, Guerrieri S, et al. Optical coherence tomography with voxel-based morphometry: a new tool to unveil focal retinal neurodegeneration in multiple sclerosis. Brain Comm. 2023;6(1):fcad249. https://doi.org/10.1093/braincomms/fcad249
  15. Meijboom R, York EN, Kampaite A, et al; FutureMS Consortium. Patterns of brain atrophy in recently-diagnosed relapsing-remitting multiple sclerosis. Pub Lib Sci. 2023;18(7):e0288967. https://doi.org/10.1371/journal.pone.0288967
  16. Menard C, Pfau ML, Hodes GE, et al. Social stress induces neurovascular pathology promoting depression. Nat Neurosci. 2017;20(12):1752-1760. https://doi.org/10.1038/s41593-017-0010-3
  17. Román Rosón M, Bauer Y, Kotkat AH, et al. Mouse dLGN Receives Functional Input from a Diverse Population of Retinal Ganglion Cells with Limited Convergence. Neuron. 2019;102(2):462-476.e8.  https://doi.org/10.1016/j.neuron.2019.01.040
  18. Papadopoulou A, Gaetano L, Pfister A, et al. Damage of the lateral geniculate nucleus in MS: Assessing the missing node of the visual pathway. Neurology. 2019;92(19):e2240-e2249. https://doi.org/10.1212/WNL.0000000000007450
  19. Mutlu U, Ikram MK, Roshchupkin GV, et al. Thinner retinal layers are associated with changes in the visual pathway: A population-based study. Hum Brain Mapp. 2018;39(11):4290-4301. https://doi.org/10.1002/hbm.24246
  20. Pulido-Valdeolivas I, Andorrà M, Gómez-Andrés D, et al. Retinal and brain damage during multiple sclerosis course: inflammatory activity is a key factor in the first 5 years. Sci Rep. 2020;10(1):13333. https://doi.org/10.1038/s41598-020-70255-z
  21. Barreiro-González A, Sanz MT, Carratalà-Boscà S, et al. Magnetic resonance imaging and optical coherence tomography correlations in multiple sclerosis beyond anatomical landmarks. J Neurol Sci. 2020;419:117180. https://doi.org/10.1016/j.jns.2020.117180
  22. Petracca M, Cordano C, Cellerino M, et al. Retinal degeneration in primary-progressive multiple sclerosis: A role for cortical lesions? Mult Scler. 2017;23(1):43-50.  https://doi.org/10.1177/1352458516637679
  23. Krämer J, Balloff C, Weise M, et al. Evolution of retinal degeneration and prediction of disease activity in relapsing and progressive multiple sclerosis. Nat Comm. 2024;15(1):5243. https://doi.org/10.1038/s41467-024-49309-7

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.